507789 Stock Overview
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Jagsonpal Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹537.55 |
| 52 Week High | ₹563.50 |
| 52 Week Low | ₹270.05 |
| Beta | 1.14 |
| 11 Month Change | 23.19% |
| 3 Month Change | 48.47% |
| 1 Year Change | 34.42% |
| 33 Year Change | 210.36% |
| 5 Year Change | 1,887.25% |
| Change since IPO | 3,033.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| 507789 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 14.5% | 2.0% | 1.8% |
| 1Y | 34.4% | 58.6% | 36.8% |
Return vs Industry: 507789 underperformed the Indian Pharmaceuticals industry which returned 58.6% over the past year.
Return vs Market: 507789 underperformed the Indian Market which returned 36.8% over the past year.
Price Volatility
| 507789 volatility | |
|---|---|
| 507789 Average Weekly Movement | 8.4% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 507789's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 507789's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 1,025 | Manish Gupta | www.jagsonpal.com |
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups.
Jagsonpal Pharmaceuticals Limited Fundamentals Summary
| 507789 fundamental statistics | |
|---|---|
| Market cap | ₹14.28b |
| Earnings (TTM) | ₹243.00m |
| Revenue (TTM) | ₹2.27b |
58.8x
P/E Ratio6.3x
P/S RatioIs 507789 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 507789 income statement (TTM) | |
|---|---|
| Revenue | ₹2.27b |
| Cost of Revenue | ₹924.50m |
| Gross Profit | ₹1.34b |
| Other Expenses | ₹1.10b |
| Earnings | ₹243.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.18 |
| Gross Margin | 59.25% |
| Net Profit Margin | 10.71% |
| Debt/Equity Ratio | 0% |
How did 507789 perform over the long term?
See historical performance and comparison